170 related articles for article (PubMed ID: 37021366)
1. Glycation reduces the binding dynamics of aflatoxin B
Qureshi MA; Amir M; Khan RH; Musarrat J; Javed S
J Biomol Struct Dyn; 2023; 41(24):14797-14811. PubMed ID: 37021366
[TBL] [Abstract][Full Text] [Related]
2. Structural dynamics studies on the binding of aflatoxin B
Aamir Qureshi M; Javed S
J Biomol Struct Dyn; 2020 Jul; 38(11):3144-3155. PubMed ID: 31378144
[TBL] [Abstract][Full Text] [Related]
3. Non-enzymatic glycation of human serum albumin modulates its binding efficacy towards bioactive flavonoid chrysin: A detailed study using multi-spectroscopic and computational methods.
Sarmah S; Pahari S; Das S; Belwal VK; Jana M; Singha Roy A
J Biomol Struct Dyn; 2021 Feb; 39(2):476-492. PubMed ID: 31900044
[TBL] [Abstract][Full Text] [Related]
4. Exploring the combination characteristics of lumefantrine, an antimalarial drug and human serum albumin through spectroscopic and molecular docking studies.
Musa KA; Ridzwan NFW; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2021 Feb; 39(2):691-702. PubMed ID: 31913089
[TBL] [Abstract][Full Text] [Related]
5. Binding site identification of metformin to human serum albumin and glycated human serum albumin by spectroscopic and molecular modeling techniques: a comparison study.
Rahnama E; Mahmoodian-Moghaddam M; Khorsand-Ahmadi S; Saberi MR; Chamani J
J Biomol Struct Dyn; 2015; 33(3):513-33. PubMed ID: 24720899
[TBL] [Abstract][Full Text] [Related]
6. Investigating binding dynamics of trans resveratrol to HSA for an efficient displacement of aflatoxin B
Qureshi MA; Javed S
Sci Rep; 2022 Feb; 12(1):2400. PubMed ID: 35165338
[TBL] [Abstract][Full Text] [Related]
7. Characterization of sulfasalazine-bovine serum albumin and human serum albumin interaction by spectroscopic and theoretical approach.
Rahman N; Khalil N
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Nov; 300():122865. PubMed ID: 37269654
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the binding of carbendazim (fungicide) with human serum albumin: A multi-spectroscopic and molecular modelling studies.
Siddiqui MF; Khan MS; Husain FM; Bano B
J Biomol Struct Dyn; 2019 Jun; 37(9):2230-2241. PubMed ID: 30047309
[TBL] [Abstract][Full Text] [Related]
9. Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach.
Kandandapani S; Kabir MZ; Ridzwan NFW; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2022 Nov; 40(18):8312-8323. PubMed ID: 33870854
[TBL] [Abstract][Full Text] [Related]
10. Aflatoxin B
Qureshi MA; Javed S
ACS Omega; 2021 Jul; 6(28):18054-18064. PubMed ID: 34308039
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the biomolecular interaction between delamanid/formulations and human serum albumin by fluorescence, CD spectroscopy and SPR: Effects on protein conformation, kinetic and thermodynamic parameters.
Tongkanarak K; Loupiac C; Neiers F; Chambin O; Srichana T
Colloids Surf B Biointerfaces; 2024 Jul; 239():113964. PubMed ID: 38761495
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the binding mechanism for a water-soluble Pd(II) complex containing β-amino alcohols with HSA applying experimental and computational methods.
Shahabadi N; Ghaffari L; Mardani Z; Hadidi S
J Biomol Struct Dyn; 2024 Apr; 42(7):3790-3801. PubMed ID: 37243704
[TBL] [Abstract][Full Text] [Related]
13. Biophysical and computational view on the
Tayyab S; Magesvaran MKA; Kabir MZ; Ridzwan NFW; Mohamad SB
J Biomol Struct Dyn; 2021 Jul; 39(10):3565-3575. PubMed ID: 32397949
[TBL] [Abstract][Full Text] [Related]
14. A multi-spectroscopic and computational simulations study to delineate the interaction between antimalarial drug hydroxychloroquine and human serum albumin.
Azeem K; Ahmed M; Mohammad T; Uddin A; Shamsi A; Hassan MI; Singh S; Patel R; Abid M
J Biomol Struct Dyn; 2023; 41(13):6377-6393. PubMed ID: 35924780
[TBL] [Abstract][Full Text] [Related]
15. Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking.
Kabir MZ; Feroz SR; Mukarram AK; Alias Z; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2016 Aug; 34(8):1693-704. PubMed ID: 26331959
[TBL] [Abstract][Full Text] [Related]
16. Spectroscopy and molecular docking approach for investigation on the binding of nocodazole to human serum albumin.
Singh I; Luxami V; Paul K
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jul; 235():118289. PubMed ID: 32222625
[TBL] [Abstract][Full Text] [Related]
17. Multispectroscopic insight, morphological analysis and molecular docking studies of Cu
Yousuf I; Bashir M; Arjmand F; Tabassum S
J Biomol Struct Dyn; 2019 Aug; 37(12):3290-3304. PubMed ID: 30124142
[TBL] [Abstract][Full Text] [Related]
18. Investigation on the interaction of newly designed potential antibacterial Zn(II) complexes with CT-DNA and HSA.
Mansouri-Torshizi H; Khosravi F; Ghahghaei A; Shahraki S; Zareian-Jahromi S
J Biomol Struct Dyn; 2018 Aug; 36(10):2713-2737. PubMed ID: 28768466
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effect of phenylpropanoids on the binding of heparin to human serum albumin and glycosylated human serum albumin concerning anticoagulant activity: A comparison study.
Akbari V; Ghobadi S
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128732. PubMed ID: 38092116
[TBL] [Abstract][Full Text] [Related]
20. Exploring the interaction between tyrphostin 9 and human serum albumin using biophysical and computational methods.
Kandandapani S; Ridzwan NFW; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2020 Sep; 38(14):4134-4142. PubMed ID: 31552810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
